Your session is about to expire
← Back to Search
Other
BOR15001L7 Cream for Cold Sores
N/A
Waitlist Available
Research Sponsored by Laboratoire Boreaderme Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Summary
The aim of this study is to determine the safety and efficacy of a topical natural health product in comparison to placebo for the treatment of herpes labialis.
Eligible Conditions
- Cold Sores
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: BOR15001L7 CreamExperimental Treatment1 Intervention
BOR15001L7 Cream with 5% 15019L0
Group II: Placebo CreamPlacebo Group1 Intervention
Placebo Cream
Find a Location
Who is running the clinical trial?
Laboratoire Boreaderme Inc.Lead Sponsor
1 Previous Clinical Trials
164 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger